Cargando…

Discontinuation of Immunosuppressive Therapy in Patients With Neuromyelitis Optica Spectrum Disorder With Aquaporin-4 Antibodies

OBJECTIVE: To evaluate the outcomes of immunosuppressive therapy (IST) discontinuation in patients with neuromyelitis optica spectrum disorder (NMOSD) after a sustained remission period. METHODS: We retrospectively reviewed the medical records of 17 patients with antiaquaporin-4 antibody-positive NM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Su-Hyun, Jang, Hyunmin, Park, Na Young, Kim, Yeseul, Kim, So-Yeon, Lee, Min Young, Hyun, Jae-Won, Kim, Ho Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903808/ https://www.ncbi.nlm.nih.gov/pubmed/33622675 http://dx.doi.org/10.1212/NXI.0000000000000947

Ejemplares similares

Comparison of Neuropathic Pain in Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis
por: Hyun, Jae-Won, et al.
Publicado: (2020)

Validation of the Korean Version of the 12-Item Multiple Sclerosis Walking Scale and Application to Neuromyelitis Optica Spectrum Disorder
por: Kim, Woojun, et al.
Publicado: (2020)

Investigating the Presence of Interattack Astrocyte Damage in Neuromyelitis Optica Spectrum Disorder: Longitudinal Analysis of Serum Glial Fibrillary Acidic Protein
por: Hyun, Jae-Won, et al.
Publicado: (2021)

Clinical Efficacy of Plasmapheresis in Patients with Neuromyelitis Optica Spectrum Disorder and Effects on Circulating Anti-Aquaporin-4 Antibody Levels
por: Kim, Su-Hyun, et al.
Publicado: (2013)

Brain Abnormalities in Neuromyelitis Optica Spectrum Disorder
por: Kim, Woojun, et al.
Publicado: (2012)

Increased frequency of IL-6-producing non-classical monocytes in neuromyelitis optica spectrum disorder
por: Kong, Byung Soo, et al.
Publicado: (2017)

Cerebral Cortex Involvement in Neuromyelitis Optica Spectrum Disorder
por: Kim, Woojun, et al.
Publicado: (2016)

Radiologically isolated aquaporin-4 antibody neuromyelitis optica spectrum disorder
por: Abdel-Mannan, Omar, et al.
Publicado: (2022)

Antibody to Aquaporin 4 in the Diagnosis of Neuromyelitis Optica
por: Paul, Friedemann, et al.
Publicado: (2007)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
por: Schanda, Kathrin, et al.
Publicado: (2015)

A Longitudinal Brain Magnetic Resonance Imaging Study of Neuromyelitis Optica Spectrum Disorder
por: Kim, Su-Hyun, et al.
Publicado: (2014)

CSF GFAP levels in double seronegative neuromyelitis optica spectrum disorder: no evidence of astrocyte damage
por: Hyun, Jae-Won, et al.
Publicado: (2022)

Molecular Level Characterization of Circulating Aquaporin-4 Antibodies in Neuromyelitis Optica Spectrum Disorder
por: Li, Jie, et al.
Publicado: (2021)

Multimodal magnetic resonance imaging in relation to cognitive impairment in neuromyelitis optica spectrum disorder
por: Kim, Su-Hyun, et al.
Publicado: (2017)

Are aquaporin antibody titers useful outcome measures for neuromyelitis optica spectrum disorders?
por: Reindl, Markus
Publicado: (2020)

Rituximab-Induced Hypogammaglobulinemia and Risk of Infection in Neuromyelitis Optica Spectrum Disorders: A 14-Year Real-Life Experience
por: Kim, Su-Hyun, et al.
Publicado: (2022)

Neuromyelitis Optica Spectrum Disorder With Anti-Aquaporin-4 Antibody: Outcome Prediction Models
por: Wang, Liang, et al.
Publicado: (2022)

Neuromyelitis optica pathogenesis and aquaporin 4
por: Graber, David J, et al.
Publicado: (2008)

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica
por: Jarius, S., et al.
Publicado: (2008)

Patterns of Antibody Binding to Aquaporin-4 Isoforms in Neuromyelitis Optica
por: Mader, Simone, et al.
Publicado: (2010)

Anti-Aquaporin-1 Autoantibodies in Patients with Neuromyelitis Optica Spectrum Disorders
por: Tzartos, John S., et al.
Publicado: (2013)

Convergence spasm due to aquaporin-positive neuromyelitis optica spectrum disorder
por: Özçelik, Pınar, et al.
Publicado: (2017)

Clinical Usefulness of Cell-based Indirect Immunofluorescence Assay for the Detection of Aquaporin-4 Antibodies in Neuromyelitis Optica Spectrum Disorder
por: Kang, Eun-suk, et al.
Publicado: (2012)

Persistent Hyperthermia in a Patient with Aquaporin-4-Antibody-Positive Neuromyelitis Optica Spectrum Disorder
por: Hsu, Chia-Lun, et al.
Publicado: (2016)

Extensive Cerebral Cortical Involvement in Aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorder
por: Ramineni, Kiran Kumar, et al.
Publicado: (2021)

Silent progression of brain atrophy in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder
por: Masuda, Hiroki, et al.
Publicado: (2022)

Aquaporin 4 antibody‐positive neuromyelitis optica spectrum disorder with cholangiocarcinoma: Casual or causal association?
por: Fang, Wei, et al.
Publicado: (2022)

Monoclonal Antibody Therapies for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
por: Kim, Woojun, et al.
Publicado: (2020)

New Insights into Neuromyelitis Optica
por: Kim, Woojun, et al.
Publicado: (2011)

Cerebrospinal Fluid Aquaporin-4 Antibody Levels in Neuromyelitis Optica Attacks
por: Sato, Douglas Kazutoshi, et al.
Publicado: (2014)

Large-Scale in-House Cell-Based Assay for Evaluating the Serostatus in Patients with Neuromyelitis Optica Spectrum Disorder Based on New Diagnostic Criteria
por: Kim, Yeseul, et al.
Publicado: (2017)

Fatal anti-aquaporin-4 seropositive neuromyelitis optica spectrum disorder in tuberculosis
por: Sridhar, Siddharth, et al.
Publicado: (2014)

Different Exosomal microRNA Profile in Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorders
por: Chen, Chen, et al.
Publicado: (2020)

Alterations in the Brain Structure and Functional Connectivity in Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder
por: Yan, Jueyue, et al.
Publicado: (2020)

The Detection of Retina Microvascular Density in Subclinical Aquaporin-4 Antibody Seropositive Neuromyelitis Optica Spectrum Disorders
por: Chen, Yihong, et al.
Publicado: (2020)

Deep learning-based relapse prediction of neuromyelitis optica spectrum disorder with anti-aquaporin-4 antibody
por: Wang, Liang, et al.
Publicado: (2022)

Neuromyelitis Optica Spectrum Disorder in a Patient with Ankylosing Spondylitis
por: Jeong, Soo, et al.
Publicado: (2018)

Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014)

Rehabilitation of neuromyelitis optica: Two CARE-compliant case reports
por: Kim, Won Bin, et al.
Publicado: (2019)

Differential diagnosis of neuromyelitis optica spectrum disorders
por: Kim, Sung-Min, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_sp76n1glbabsn2ts6470229dm4